Cargando…
Preclinical Cancer Models and Biomarkers for Drug Development: New Technologies and Emerging Tools
BACKGROUND AND PURPOSE: Predicting the efficacy of anticancer therapy is the holy grail of drug development and treatment selection in the clinic. To achieve this goal, scientists require pre-clinical models that can reliably screen anticancer agents with robust clinical correlation. However, there...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743226/ https://www.ncbi.nlm.nih.gov/pubmed/29285415 http://dx.doi.org/10.4172/2155-9929.1000356 |